Phase 2, randomized dose-finding study of tapinarof (GSK2894512 cream) for the treatment of plaque psoriasis

There is a significant need for novel, safe, and efficacious topical treatments for psoriasis. We assessed the safety and efficacy of tapinarof in a new cream formulation at 2 concentrations and with 2 application frequencies in adults with psoriasis. Double-blind, vehicle-controlled, randomized, 6-...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of the American Academy of Dermatology 2019-03, Vol.80 (3), p.714-721
Hauptverfasser:	Robbins, Kevin, Bissonnette, Robert, Maeda-Chubachi, Tomoko, Ye, Li, Peppers, Johnny, Gallagher, Kelly, Kraus, John E.
Format:	Artikel
Sprache:	eng
Schlagworte:	GSK2894512 psoriasis TAMA tapinarof therapeutic AhR (aryl hydrocarbon receptor) modulating agent
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!